---
layout: post
title: "Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress"
date: 2026-02-05T07:22:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/sobi-q4-and-fy-2025-report-closing-the-year-with-significant-growth-and-strategic-progress-302679912.html
significance: 7.00
---

<p>STOCKHOLM, Feb. 5, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (SobiÂ®) today announced its report for the fourth quarter and full year of 2025. Fourth Quarter 2025 Total revenue increased 5 per cent, 16 per cent at CER1, to SEK 7,821 M (7,436) Haematology revenue increased 25...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/sobi-q4-and-fy-2025-report-closing-the-year-with-significant-growth-and-strategic-progress-302679912.html)

**Published:** 2026-02-05 07:22:00 +0000

**Significance Score:** 7.00

[View original](https://www.prnewswire.com/news-releases/sobi-q4-and-fy-2025-report-closing-the-year-with-significant-growth-and-strategic-progress-302679912.html)
